Sandra DePorter, PhD

Senior Director, Discovery Biology and Chemistry at Adaxion Therapeutics

Speaker

Sandra DePorter is the Senior Director of Discovery Biology and Chemistry at ADAXION Therapeutics and a founding member of the team that developed its core technology, which originated at Inception Therapeutics. At Inception, she was Associate Director of Protein Engineering and supported seed-stage ventures like Lycia, Belharra, and Light Horse Therapeutics. Previously, she was an Investigator at Novartis (GNF), focusing on antibody conjugates for immuno-oncology. Prior to Novartis, Sandra completed a joint postdoctoral fellowship in bioengineering and cardiovascular medicine at Stanford. Sandra holds a Ph.D. in chemistry from Colorado State University and B.S. in chemistry from the University of Wisconsin-Madison.